Increasing shift from islet antibody positivity to diabetes

Increasing shift from islet antibody positivity to diabetes

(HealthDay) -- There is an increase in both the prevalence and levels of islet antigen-2 and zinc transporter 8, as well as in autoantibodies, in newly diagnosed type 1 diabetes patients during a period of rising disease incidence, according to a study published in the March issue of Diabetes.

Anna E. Long, of the University of Bristol in the United Kingdom, and colleagues analyzed autoantibodies to insulin (IAA), (GADA), islet antigen-2 (IA-2A), and zinc transporter 8 (ZnT8A) by measurement with radioimmunoassay of sera collected from children and young adults with newly diagnosed between 1985 and 2002.

The researchers found that the prevalence of IA-2A and ZnT8A increased significantly over the period studied. This finding was accompanied by raised levels of IA-2A, ZnT8A, and IA-2β autoantibodies (IA-2βA). No changes were observed in IAA or GADA prevalence and levels.

"Increases in IA-2A, ZnT8A, and IA-2βA at diagnosis during a period of rising incidence suggest that the process leading to type 1 diabetes is now characterized by a more intense humoral autoimmune response," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

G299.2-2.9, a middle-aged supernova remnant

date Oct 13, 2011

(PhysOrg.com) -- G299.2-2.9 is an intriguing supernova remnant found about 16,000 light years away in the Milky Way galaxy. Evidence points to G299.2-2.9 being the remains of a Type Ia supernova, where a white ...

New clues to pancreatic cells' destruction in diabetes

date Feb 03, 2009

Researchers have found what appears to be a major culprit behind the loss of insulin-producing β cells from the pancreases of people with diabetes, a critical event in the progression of the disease.

Dramatic increase of Type 1 diabetes in under fives

date Mar 16, 2007

Researchers are calling for more work in to the reasons behind a big increase of young children with Type 1 diabetes. A new study, led by Bristol University, has discovered that the number of children under five-years-old ...

Recommended for you

Adapted diabetes prevention program deemed effective

date 6 hours ago

(HealthDay)—An adapted Diabetes Prevention Program (DPP) lifestyle intervention significantly improves cardiovascular disease-related risk factors among participants, according to a study published in the ...

Diabetes drug helps people lose weight: study

date Jul 01, 2015

Liraglutide, an injectable diabetes drug that US regulators approved last year for weight loss, helped obese people lose an average of 18 pounds (eight kilograms), a yearlong study said Wednesday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.